These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29653432)

  • 1. In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors.
    Begum S; Nizami SS; Mahmood U; Masood S; Iftikhar S; Saied S
    Comput Biol Chem; 2018 Jun; 74():212-217. PubMed ID: 29653432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
    Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
    Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship investigation of benzamide and picolinamide derivatives containing dimethylamine side chain as acetylcholinesterase inhibitors.
    Gao XH; Liu LB; Liu HR; Tang JJ; Kang L; Wu H; Cui P; Yan J
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):110-114. PubMed ID: 29166796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors.
    Nakayama K; Schwans JP; Sorin EJ; Tran T; Gonzalez J; Arteaga E; McCoy S; Alvarado W
    Bioorg Med Chem; 2017 Jun; 25(12):3171-3181. PubMed ID: 28416102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
    Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
    Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
    Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
    Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
    Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
    Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
    Mostofi M; Mohammadi Ziarani G; Lashgari N
    Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities.
    Takao K; Toda K; Saito T; Sugita Y
    Chem Pharm Bull (Tokyo); 2017; 65(11):1020-1027. PubMed ID: 29093288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
    Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
    Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitory alkaloids from the rhizomes of Coptis chinensis.
    Cao TQ; Ngo QT; Seong SH; Youn UJ; Kim JA; Kim J; Kim JC; Woo MH; Choi JS; Min BS
    Bioorg Chem; 2018 Apr; 77():625-632. PubMed ID: 29502023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
    Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
    Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.